Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians

Journal of the American Board of Family Practice

Volumn 15, Issue 4, 2002, Pages 277-284

  Magri, Julie M ^a,b   Johnson, Melissa T ^b   Herring, Timothy A ^b   Greenblatt, Jesse F ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Off of Community and Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC ERROR; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY CARE PHYSICIAN; PRIMARY MEDICAL CARE; QUESTIONNAIRE; UNITED STATES; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDY; GENERAL PRACTITIONER; HEALTH SERVICES RESEARCH; INCIDENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; STANDARD;

ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; LIPOPROTEINS; LYME DISEASE; NEW HAMPSHIRE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; RISK FACTORS;

EID: 0036632241     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Surveillance for Lyme disease - United States, 1992-1998. Morb Mortal Wkly Rep CDC Surveill Summ 2000;49:1-11.
2. White DJ, Chang HG, Benach JL, et al. The geographic spread and temporal increase of the Lyme disease epidemic. JAMA 1991;266:1230-6.
3. American Academy of Pediatrics Committee on Infectious Diseases. Treatment of Lyme borreliosis. Pediatrics 1991;88:176-9.
4. American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of Lyme disease. Pediatrics 2000;105(1 Pt 1):142-7.
5. American College of Physicians initiative on Lyme disease - guide to clinical practice. Philadelphia: American College of Physicians, 1998.
6. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. American College of Physicians. Ann Intern Med 1997;127:1106-8.
7. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590-1.
8. FDA public health advisory: assays for antibodies to Borrelia burgdorferi; limitations, use, and interpretation for supporting a clinical diagnosis of Lyme disease. Rockville, Md: US Food and Drug Administration, 1997.
9. Eppes SC, Klein JD, Caputo GM, Rose CD. Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area. Clin Pediatr (Phila) 1994;33:130-4.
10. Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 1996;24:82-6.
11. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-7):1-17, 21-25.
12. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1997;46(RR-10):20-1.
13. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
14. Dennis DT, Meltzer MI. Antibiotic prophylaxis after tick bites. Lancet 1997;350:1191-2.
15. Ettestad PJ, Campbell GL, Welbel SF, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995;171:356-61.
16. Nadelman RB, Wormser GP. Management of tick bites and early Lyme disease. In: Rahn DW, Evans J, editors. Lyme disease. Philadelphia: American College of Physicians, 1998.
17. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998;128:354-62.
18. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician 1997;55:1647-54, 1657-8.
19. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996;128:757-64.
20. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996;313:387-91.
21. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA 1996;275:206-9.
22. Sigal LH. Long-term consequences of Lyme disease. In: Rahn DW, Evans J, editors. Lyme disease. Philadelphia: American College of Physicians, 1998.
23. Sigal LH. The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement. Arch Intern Med 1996;156:1493-500.
24. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States. Emerg Infect Dis 1999;5:635-42.
25. Benach JL, Coleman JL, Habicht GS, MacDonald A, Grunwaldt E, Giron JA. Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J Infect Dis 1985;152:473-7.
26. Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.
27. Magnarelli LA, Dumler JS, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tickborne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995;33:3054-7.
28. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996;34:724-7.
29. Nadelman RB, Horowitz HW, Hsieh TC, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997;337:27-30.
30. Herring T. Case report: human granulocytic ehrlichiosis in a New Hampshire resident. New Hampshire Office of Community and Public Health. Commun Dis Bull 1999;5(4):1,4.
31. Sole Lyme disease vaccine is pulled off market. New York Times Feb 28, 2002;sect c:5 (col 2).
32. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
33. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993;329:1271-3.
34. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-11.
35. Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med 1993;153:2646-55.
36. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 1990;263:549-56.
37. Thomson O'Brien T, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software.